Wayne Winegarden

Health Care

ISSUE BRIEF: Government Policy Is Consolidating the Practice of Medicine

A new issue brief released today by the Pacific Research Institute—the California-based, nonpartisan, free market think tank—finds that certain states’ efforts to tighten corporate practice of medicine laws hurt independent physicians, empower hospitals to consolidate local provider markets, and raise healthcare costs. “Competition is a prerequisite for affordable, high-quality care,” ...
Blog

Spending Watch

Spending Watch: The Taxing Wealth Tax

The Taxing Wealth Tax Wayne Winegarden February 2026 To his credit, Governor Newsom is vowing to stop the wealth tax. As we noted in our response to Governor Newsom’s January budget, just the possibility that a 5 percent wealth tax will appear on the November ballot is having a chilling ...
Blog

Spending Watch

Spending Watch: California’s Budget Delusion

Spending Watch: California’s Budget Delusion Wayne Winegarden January 2026 Governor Newsom has released his final state budget and for the fourth year in a row, the state is facing a large budget deficit that it must close. This prolonged period of persistent budget deficits was entirely predictable. For the upcoming ...
Blog

Forget the Trade Deficit, Growing Imports Are a Bullish Sign for the Economy

The Bureau of Economic Analysis (BEA) just released its monthly report on international trade in goods and services for August 2025. Based on the news coverage, it would seem that the 23.8 percent decline in the trade deficit was the most important takeaway. And this decline is surely viewed as ...
Blog

Spending Watch

Spending Watch: The Unpleasant Arithmetic of a California Wealth Tax

Spending Watch: The Unpleasant Arithmetic of a California Wealth Tax Wayne Winegarden October 2025 A just proposed initiative to impose a one-time wealth tax on billionaires summarizes why California has fallen from the fourth to the fifth largest economy in the world. State policymakers continually view the private sector as ...
Blog

Ronald Reagan Opposed Tariffs – And For Good Reason

Having worked with Dr. Laffer for several years, I heard him explain the tenets of supply-side economics, or “the five pillars of prosperity” many times. These policies are (1) a low-rate broad-based flat tax; (2) a moderate level of government spending to ensure that the benefits from the government program ...
Blog

Learn How Drug Price Controls Hurt Patients

Big Pharma Is Not Gouging Americans nor Driving Up Healthcare Costs

Whether it is Sanders vilifying pharmaceutical companies or Trump’s emphasis on imposing price controls, they both allege that drug spending is a primary driver of the nation’s rising healthcare costs. Even a cursory look at the data demonstrates their focus is misplaced. Let’s start with the national health expenditure data ...
Blog

Spending Watch

California’s FY2025-26 Budget Failed to Address the State’s Long-term Financial Risks

California’s FY2025-26 Budget Failed to Address the State’s Long-term Financial Risks Wayne Winegarden October 2025 Politicians too often assume that California’s fiscal health is synonymous with the state of its annual budget. When revenue growth is strong, the state is allegedly in a sound fiscal position. It is only when ...
Drug Prices

NEW BRIEF: New California Medi-Cal Restrictions Will Hurt Patients; Competition Key to Affordable, High-Quality Health Care

SACRAMENTO – As California prepares to restrict access to proven private health insurers for dual eligible Medicare and Medi-Cal patients, the Center for Medical Economics and Innovation at the Pacific Research Institute – the nonpartisan, California-based, free market think tank – today released a new brief showing that expanding competition—not ...
Commentary

The Administration Risks Drug Shortages That Will Cost Patients Dearly

Judged by its actions, the Trump Administration supports drug shortages. Clearly, this is not the President’s stated goal, but it is the inevitable result of his policies including his proposed drug tariffs and most favored nation (MFN) policies. Read the op-ed here.
Health Care

ISSUE BRIEF: Government Policy Is Consolidating the Practice of Medicine

A new issue brief released today by the Pacific Research Institute—the California-based, nonpartisan, free market think tank—finds that certain states’ efforts to tighten corporate practice of medicine laws hurt independent physicians, empower hospitals to consolidate local provider markets, and raise healthcare costs. “Competition is a prerequisite for affordable, high-quality care,” ...
Blog

Spending Watch

Spending Watch: The Taxing Wealth Tax

The Taxing Wealth Tax Wayne Winegarden February 2026 To his credit, Governor Newsom is vowing to stop the wealth tax. As we noted in our response to Governor Newsom’s January budget, just the possibility that a 5 percent wealth tax will appear on the November ballot is having a chilling ...
Blog

Spending Watch

Spending Watch: California’s Budget Delusion

Spending Watch: California’s Budget Delusion Wayne Winegarden January 2026 Governor Newsom has released his final state budget and for the fourth year in a row, the state is facing a large budget deficit that it must close. This prolonged period of persistent budget deficits was entirely predictable. For the upcoming ...
Blog

Forget the Trade Deficit, Growing Imports Are a Bullish Sign for the Economy

The Bureau of Economic Analysis (BEA) just released its monthly report on international trade in goods and services for August 2025. Based on the news coverage, it would seem that the 23.8 percent decline in the trade deficit was the most important takeaway. And this decline is surely viewed as ...
Blog

Spending Watch

Spending Watch: The Unpleasant Arithmetic of a California Wealth Tax

Spending Watch: The Unpleasant Arithmetic of a California Wealth Tax Wayne Winegarden October 2025 A just proposed initiative to impose a one-time wealth tax on billionaires summarizes why California has fallen from the fourth to the fifth largest economy in the world. State policymakers continually view the private sector as ...
Blog

Ronald Reagan Opposed Tariffs – And For Good Reason

Having worked with Dr. Laffer for several years, I heard him explain the tenets of supply-side economics, or “the five pillars of prosperity” many times. These policies are (1) a low-rate broad-based flat tax; (2) a moderate level of government spending to ensure that the benefits from the government program ...
Blog

Learn How Drug Price Controls Hurt Patients

Big Pharma Is Not Gouging Americans nor Driving Up Healthcare Costs

Whether it is Sanders vilifying pharmaceutical companies or Trump’s emphasis on imposing price controls, they both allege that drug spending is a primary driver of the nation’s rising healthcare costs. Even a cursory look at the data demonstrates their focus is misplaced. Let’s start with the national health expenditure data ...
Blog

Spending Watch

California’s FY2025-26 Budget Failed to Address the State’s Long-term Financial Risks

California’s FY2025-26 Budget Failed to Address the State’s Long-term Financial Risks Wayne Winegarden October 2025 Politicians too often assume that California’s fiscal health is synonymous with the state of its annual budget. When revenue growth is strong, the state is allegedly in a sound fiscal position. It is only when ...
Drug Prices

NEW BRIEF: New California Medi-Cal Restrictions Will Hurt Patients; Competition Key to Affordable, High-Quality Health Care

SACRAMENTO – As California prepares to restrict access to proven private health insurers for dual eligible Medicare and Medi-Cal patients, the Center for Medical Economics and Innovation at the Pacific Research Institute – the nonpartisan, California-based, free market think tank – today released a new brief showing that expanding competition—not ...
Commentary

The Administration Risks Drug Shortages That Will Cost Patients Dearly

Judged by its actions, the Trump Administration supports drug shortages. Clearly, this is not the President’s stated goal, but it is the inevitable result of his policies including his proposed drug tariffs and most favored nation (MFN) policies. Read the op-ed here.
Scroll to Top